- Capital Cube•3 months ago
Medicamen Biotech Ltd. relative valuation is now OVERVALUED. It was previously rated NEUTRAL, and has a fundamental analysis score of 22.Our analysis is based on comparing Medicamen Biotech Ltd. with the following peers – Coral Laboratories Limited, Natural Capsules Limited and Gufic Biosciences Limited (524506-IN, 524654-IN and 509079-IN).Relative ValuationMedicamen Biotech Ltd.’s price of INR 84.400 […] (Read more...) The post Medicamen Biotech Ltd. : Overvalued relative to peers, but may deserve another look appeared first on CapitalCube.
We're sorry this is all we were able to find about this topic.
Medicamen Biotech Ltd.BSE
|52wk Range||16.00 - 105.90|
|Day's Range||105.90 - 105.90|
|Avg Vol (3m)||15,868|
As of 5:32 AM EDT. Market closed.